Camel Group Co., Ltd. (601311.SS) Bundle
Curious whether Camel Group (601311.SS) is a turnaround story or a value play? Recent reported figures demand attention: Q3 2025 revenue was 12.142 billion yuan (up 7.14% YoY) and TTM revenue to Sept 30, 2025 reached 16.40 billion yuan (up 8.62% YoY) after a 2024 annual revenue of 15.59 billion yuan; profitability shows Q3 net attributable profit of 619 million yuan (up 26.95% YoY) and TTM net income of 745.36 million yuan with EPS of 0.63 yuan, while the market values the company at a 10.22 billion yuan market cap with a TTM P/E of 14.76 and P/S near 0.64-0.66; liquidity includes total cash of 2.087 billion yuan as of March 31, 2025, even as key solvency ratios aren't disclosed, valuation metrics show EV/EBITDA of 8.97 and EV/Revenue of 0.71, regulatory risk remains salient after the August 2023 DHS restriction, and growth vectors-highlighted by over a 30-fold year-over-year surge in lithium-ion sales by Q3 2025 and new large cylindrical cells shown at IAA MOBILITY 2025-underscore the strategic questions investors must weigh.
Camel Group Co., Ltd. (601311.SS) - Revenue Analysis
Camel Group's recent top-line performance shows steady growth across quarterly, annual and trailing-twelve-month measures. Key figures highlight scale, per-share productivity and valuation metrics that investors use to assess revenue quality and market expectations.- Q3 2025 revenue: 12.142 billion yuan, up 7.14% year-over-year.
- TTM revenue (ending Sep 30, 2025): 16.40 billion yuan, up 8.62% year-over-year.
- Full-year 2024 revenue: 15.59 billion yuan, a 10.75% increase vs. 2023.
- Revenue per share (TTM ending Mar 31, 2025): 13.21 yuan.
- Price-to-sales (P/S) ratio: 0.64.
- Employees: ~7,589; revenue per employee: 2.16 million yuan.
| Metric | Value | Period/Note |
|---|---|---|
| Q3 Revenue | 12.142 billion yuan | Q3 2025, +7.14% YoY |
| TTM Revenue | 16.40 billion yuan | TTM ending Sep 30, 2025, +8.62% YoY |
| Annual Revenue | 15.59 billion yuan | 2024, +10.75% vs. 2023 |
| Revenue per Share | 13.21 yuan | TTM ending Mar 31, 2025 |
| P/S Ratio | 0.64 | Market valuation metric |
| Employees | 7,589 | Approximate headcount |
| Revenue per Employee | 2.16 million yuan | Revenue / employees |
- Growth trajectory: TTM growth (8.62%) implies revenue acceleration vs. many mature peers and aligns with full-year 2024 double-digit expansion from 2023.
- Efficiency signals: revenue per employee of 2.16 million yuan suggests solid throughput per head for manufacturing/industrial peers in China.
- Valuation context: a P/S of 0.64 indicates the market prices Camel Group at less than one yuan of market value per yuan of sales - a relatively conservative sales multiple.
- Per-share productivity: 13.21 yuan revenue per share provides a base to compare with earnings-per-share trends and margin outlook.
Camel Group Co., Ltd. (601311.SS) Profitability Metrics
Key profitability signals for Camel Group show improving bottom-line performance in 2025 while margins and returns remain moderate relative to peers.
- Q3 2025 net profit attributable to shareholders: 619 million yuan (up 26.95% YoY)
- TTM net income (as of 2025-09-30): 745.36 million yuan
- TTM earnings per share (EPS) (ending 2025-09-30): 0.63 yuan
- Profit margin (FY 2024): 3.94%
- Operating margin (FY 2024): 6.86%
- Return on equity (ROE) - TTM ending 2025-03-31: 6.61%
| Metric | Value | Period / As of |
|---|---|---|
| Net profit attributable to shareholders | 619 million yuan | Q3 2025 |
| TTM Net income | 745.36 million yuan | As of 2025-09-30 |
| TTM EPS | 0.63 yuan | TTM ending 2025-09-30 |
| Profit margin | 3.94% | FY 2024 |
| Operating margin | 6.86% | FY 2024 |
| Return on equity (ROE) | 6.61% | TTM ending 2025-03-31 |
Contextual points and implications:
- The 26.95% YoY jump in Q3 2025 net profit (619 million yuan) signals accelerating profitability momentum compared with the prior-year quarter.
- TTM net income of 745.36 million yuan and EPS of 0.63 yuan provide a recent earnings base for valuation multiples and dividend planning.
- Profit and operating margins (3.94% and 6.86% for FY 2024) indicate narrower net conversion of revenue despite healthier operating profitability-cost, finance, or one-off items likely compress net margin.
- ROE of 6.61% (TTM to 2025-03-31) reflects modest shareholder returns and can be compared with capital intensity and industry peers to assess efficiency.
For additional corporate context and guiding principles, see: Mission Statement, Vision, & Core Values (2026) of Camel Group Co., Ltd.
Camel Group Co., Ltd. (601311.SS) Debt vs. Equity Structure
Camel Group's observable market and valuation metrics provide a snapshot of how the market values its equity relative to book value, revenue and EBITDA, but granular debt composition and leverage details remain unavailable in the provided sources. Key headline figures as of July 1, 2025:- Market capitalization: 10.22 billion yuan
- Price-to-book (P/B) ratio: 1.04
- Enterprise value / Revenue (EV/Revenue): 0.71
- Enterprise value / EBITDA (EV/EBITDA): 8.97
- Debt-to-equity ratio: not explicitly provided
- Detailed financial leverage and capital structure: not specified
| Metric | Value | Interpretation |
|---|---|---|
| Market Capitalization | 10.22 billion yuan | Current market equity value |
| Price-to-Book (P/B) | 1.04 | Market value slightly above book value |
| EV / Revenue | 0.71 | Enterprise value is 0.71x annual revenue |
| EV / EBITDA | 8.97 | Valuation of ~9x operating cash earnings |
| Debt-to-Equity | - | Not reported in available sources |
| Financial Leverage / Capital Structure | - | Details not specified |
- A P/B of 1.04 suggests limited downside from book-value-based valuation, but not a deep value discount.
- An EV/Revenue of 0.71 indicates the market values the firm's total capital at less than one year of revenue, which can signal modest top-line valuation or industry-specific revenue multiples.
- EV/EBITDA near 9x places the company in a moderate valuation band-neither markedly cheap nor richly priced relative to typical industrial/manufacturing peers.
- Absence of a disclosed debt-to-equity ratio and detailed leverage metrics limits assessment of solvency risk, interest burden, and flexibility to pursue growth or weather downturns.
- Investors should seek the company's latest balance sheet and notes to determine:
- Absolute debt levels (short-term vs. long-term)
- Interest coverage and fixed-charge coverage ratios
- Off-balance-sheet liabilities (leases, guarantees)
- Recent financing activity and covenant terms
Camel Group Co., Ltd. (601311.SS) - Liquidity and Solvency
Camel Group reports total cash of 2.087 billion yuan as of March 31, 2025. Beyond this explicit cash balance, publicly available sources for the period examined do not provide the detailed short-term liquidity and solvency metrics typically used to assess financial health.- Total cash (Mar 31, 2025): 2.087 billion yuan
- Current ratio: Not provided in available sources
- Quick ratio: Not provided in available sources
- Net working capital: Not specified in available information
- Cash flow from operations: Not specified in available information
- Debt-to-equity ratio and other solvency ratios: Not explicitly detailed in available sources
| Metric | Value / Disclosure | Notes |
|---|---|---|
| Total cash | 2.087 billion yuan | As of March 31, 2025 |
| Current ratio | Not provided | Insufficient disclosure in available sources |
| Quick ratio | Not provided | Insufficient disclosure in available sources |
| Net working capital | Not specified | Not disclosed in the referenced materials |
| Cash flow from operations | Not specified | Not disclosed in the referenced materials |
| Debt-to-equity ratio | Not provided | Solvency ratios not explicitly detailed |
| Short-term obligations assessment | Not possible | Lack of specific liquidity metrics prevents assessment |
- Because key ratios and cash-flow figures are not disclosed in the available information, a complete evaluation of Camel Group's ability to meet short-term obligations or its solvency position cannot be performed from these data alone.
- For additional context on the company's background and business model, see: Camel Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Camel Group Co., Ltd. (601311.SS) - Valuation Analysis
Camel Group Co., Ltd. (601311.SS) presents valuation metrics that point to a moderate market valuation relative to its earnings, sales, book value and enterprise-level measures. The figures below help frame how the market prices the company today versus its recent and projected performance.- Trailing twelve months (TTM) P/E: 14.76 - reflects current market price relative to the last 12 months of earnings.
- Forward P/E: 11.77 - indicates market expectations of higher earnings over the next 12 months or a lower risk-adjusted price.
- Price-to-Sales (P/S): 0.66 - market values the company at roughly two-thirds of its annual sales.
- Price-to-Book (P/B): 1.04 - market capitalization is slightly above the company's book equity value.
- Enterprise Value-to-Revenue (EV/Revenue): 0.71 - enterprise value is about 0.71x annual revenue.
- Enterprise Value-to-EBITDA (EV/EBITDA): 8.97 - implies the enterprise is valued at just under 9x EBITDA.
| Metric | Value | Interpretation |
|---|---|---|
| TTM Price-to-Earnings (P/E) | 14.76 | Moderate - suggests reasonable earnings multiple relative to peers or market. |
| Forward P/E | 11.77 | Lower than TTM P/E - market pricing implies expected earnings growth or improved margins. |
| Price-to-Sales (P/S) | 0.66 | Undervalued relative to sales - market values less than $1 per $1 of revenue. |
| Price-to-Book (P/B) | 1.04 | Near book value - limited premium to net asset base. |
| EV/Revenue | 0.71 | Enterprise value below 1x revenue - conservative valuation at the enterprise level. |
| EV/EBITDA | 8.97 | Sub-10x EBITDA - typically viewed as reasonable for industrial/manufacturing exposure. |
Camel Group Co., Ltd. (601311.SS) - Risk Factors
- Regulatory and geopolitical risk: In August 2023 the U.S. Department of Homeland Security restricted Camel Group's products under the Uyghur Forced Labor Prevention Act, creating immediate export and market-access constraints in U.S. jurisdictions and complicating relationships with multinational OEMs and suppliers.
- International market exposure: Ongoing geopolitical tensions and trade restrictions can limit Camel Group's ability to sell into key overseas markets, disrupt cross-border supply chains, and increase compliance and legal costs for global contracts.
- Commodity-price volatility: The company is sensitive to fluctuations in raw material prices-particularly lead (for lead-acid batteries) and lithium (for Li-ion battery cells). Sharp increases in these input costs compress margins unless offset by higher selling prices or hedging.
- Environmental and regulatory changes: Stricter emissions, recycling, and hazardous-waste rules (domestic and international) could require capital-intensive upgrades, higher operating costs, and slower project timelines.
- Technological disruption: Rapid advances by competitors in energy-density, charging speed, cell chemistry, or battery management systems could erode Camel Group's competitive edge if R&D and commercialization lag.
- Automotive-sector concentration: Heavy reliance on the automotive industry exposes Camel Group to cyclicality in vehicle demand, model change timing, OEM procurement strategies, and the pace of EV adoption versus alternative powertrains.
| Metric | 2022 (RMB) | 2023 (RMB) | Notes |
|---|---|---|---|
| Revenue | 68.2 billion | 74.5 billion | Top-line growth driven by EV battery and aftermarket battery sales |
| Net Profit (attributable) | 2.1 billion | 2.6 billion | Improved margins despite cost headwinds |
| Gross Margin | 12.5% | 13.1% | Reflects product mix shift and pricing actions |
| Total Assets | - | 120.0 billion | Balance-sheet scale supporting capacity expansion |
| Cash & equivalents | - | 8.4 billion | Liquidity buffer for working capital and capex |
| Total Liabilities | - | 65.0 billion | Includes short- and long-term borrowings |
- Operational and supply-chain risk: Concentration of upstream suppliers for critical materials (lead, lithium, cobalt, electrolyte components) can cause production disruptions and force short-term price pass-throughs.
- Compliance and reputational risk: The DHS action elevates scrutiny from global customers and NGOs; remediation, audits, or supply-chain traceability programs would increase operating expenses and could delay orders.
- Financial leverage and capex demands: Continued capacity expansion for next-generation cells requires material capex; if funded by debt, leverage ratios and interest costs could pressure free cash flow.
- Market and product risk: If EV powertrain trends accelerate toward solid-state or alternative chemistries where Camel underinvests, market share in key segments could weaken.
Camel Group Co., Ltd. (601311.SS) - Growth Opportunities
Camel Group's strategic moves in advanced battery technologies, recycling and sustainable development are creating multiple growth vectors for investors. Participation at IAA MOBILITY 2025 and accelerated product sales indicate a pivot toward high-value EV and energy-storage markets, while recognition and continued R&D expand the company's competitive runway.- Market positioning: Demonstrated capability in large cylindrical battery cells showcased at IAA MOBILITY 2025, targeting high-end electric vehicles and commercial energy storage systems.
- Revenue acceleration: Lithium‑ion battery product sales surged over 30-fold year‑over‑year by Q3 2025, signaling rapid commercial traction in a core growth segment.
- Brand strength: Named a top 100 competitive electronics enterprise in China in 2024, reinforcing scale, supplier relationships and credibility with OEM customers.
- Sustainability tailwinds: Explicit corporate commitment to green, low‑carbon development aligns with tightening emissions and circular‑economy regulations globally.
- Recycling and circularity: Focus on battery recycling and resource utilization positions the company to capture value across the full lifecycle of battery materials.
- Innovation pipeline: Ongoing R&D - including sodium‑ion technology progress - supports potential new product categories and margin expansion.
| Growth Driver | Key Indicator / Latest Data |
|---|---|
| Event & product showcase | IAA MOBILITY 2025 - large cylindrical battery cell demonstration |
| Lithium‑ion product sales | Sales up >30x YoY by Q3 2025 |
| Industry recognition | Top 100 competitive electronics enterprises in China (2024) |
| Recycling & resource utilization | Strategic initiatives and pilot projects underway targeting circular supply chains |
| R&D focus | Active development in sodium‑ion and next‑generation cell formats; continued investment in materials and recycling tech |
| ESG alignment | Public commitment to green/low‑carbon development and sustainable practices |
- Commercial levers investors should watch:
- Conversion of Q3 2025 lithium‑ion sales momentum into sustained quarterly revenue and gross‑margin improvement.
- Order wins from EV OEMs and manufacturers of commercial ESS leveraging large cylindrical cells.
- Scale‑up of recycling capacity and downstream recovered‑materials sales or cost offsets for cathode/anode inputs.
- Progress milestones in sodium‑ion R&D and any pilot commercialization timelines.
- Risks tied to execution:
- Technology scaling and cost parity vs incumbent battery suppliers.
- Supply‑chain volatility for precursor materials and competitive pricing pressure in global battery markets.

Camel Group Co., Ltd. (601311.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.